The University of Chicago Header Logo

Connection

Jeffrey Hubbell to Protein Engineering

This is a "connection" page, showing publications Jeffrey Hubbell has written about Protein Engineering.
Connection Strength

2.654
  1. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016 Jan; 30:1-12.
    View in: PubMed
    Score: 0.483
  2. Drug development: longer-lived proteins. Chem Soc Rev. 2012 Apr 07; 41(7):2686-95.
    View in: PubMed
    Score: 0.373
  3. Drug development: Longer-lived proteins. Nature. 2010 Oct 28; 467(7319):1051-2.
    View in: PubMed
    Score: 0.341
  4. Improving protein pharmacokinetics by engineering erythrocyte affinity. Mol Pharm. 2010 Dec 06; 7(6):2141-7.
    View in: PubMed
    Score: 0.338
  5. Immunoengineering approaches for cytokine therapy. Am J Physiol Cell Physiol. 2021 08 01; 321(2):C369-C383.
    View in: PubMed
    Score: 0.179
  6. Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models. Arthritis Rheumatol. 2021 05; 73(5):769-778.
    View in: PubMed
    Score: 0.175
  7. Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials. Biomaterials. 2017 Aug; 135:1-9.
    View in: PubMed
    Score: 0.134
  8. Engineering antigen-specific immunological tolerance. Curr Opin Immunol. 2015 Aug; 35:80-8.
    View in: PubMed
    Score: 0.118
  9. Molecularly engineered self-assembling membranes for cell-mediated degradation. Adv Healthc Mater. 2015 Mar 11; 4(4):602-12.
    View in: PubMed
    Score: 0.113
  10. Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials. 2010 Feb; 31(6):1219-26.
    View in: PubMed
    Score: 0.080
  11. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005 Jan; 23(1):47-55.
    View in: PubMed
    Score: 0.057
  12. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004 Jul; 25(16):3245-57.
    View in: PubMed
    Score: 0.055
  13. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules. 2002 Jul-Aug; 3(4):710-23.
    View in: PubMed
    Score: 0.048
  14. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials. 2017 07; 131:160-175.
    View in: PubMed
    Score: 0.033
  15. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science. 2014 Feb 21; 343(6173):885-8.
    View in: PubMed
    Score: 0.027
  16. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials. 2013 Aug; 34(24):5958-68.
    View in: PubMed
    Score: 0.025
  17. Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):E60-8.
    View in: PubMed
    Score: 0.025
  18. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (N Y). 1991 Jun; 9(6):568-72.
    View in: PubMed
    Score: 0.022
  19. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng. 2005 Feb 05; 89(3):253-62.
    View in: PubMed
    Score: 0.014
  20. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004 Apr 30; 94(8):1124-32.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.